Janux Therapeutics, Inc. (NASDAQ: JANX) reported Q2 EPS of ($0.35), $0.08 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $10.27 million versus the consensus estimate of $17.94 million.

For earnings history and earnings-related data on Janux Therapeutics, Inc. (JANX) click here.